Cargando…

Mutational signatures in squamous cell carcinoma of the lung

BACKGROUND: Tumor mutational burden (TMB) has been identified as one of the predictors for the response to anti-programmed cell death-1 (anti-PD-1) antibody therapy and reported to correlate with smoking history in lung adenocarcinoma. However, in squamous cell carcinoma of the lung, the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Osoegawa, Atsushi, Takada, Kazuki, Okamoto, Tatsuro, Sato, Seijiro, Nagahashi, Masayuki, Tagawa, Tetsuzo, Tsuchida, Masanori, Oki, Eiji, Okuda, Shujiro, Wakai, Toshifumi, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947495/
https://www.ncbi.nlm.nih.gov/pubmed/33717580
http://dx.doi.org/10.21037/jtd-20-2602
_version_ 1783663240934326272
author Osoegawa, Atsushi
Takada, Kazuki
Okamoto, Tatsuro
Sato, Seijiro
Nagahashi, Masayuki
Tagawa, Tetsuzo
Tsuchida, Masanori
Oki, Eiji
Okuda, Shujiro
Wakai, Toshifumi
Mori, Masaki
author_facet Osoegawa, Atsushi
Takada, Kazuki
Okamoto, Tatsuro
Sato, Seijiro
Nagahashi, Masayuki
Tagawa, Tetsuzo
Tsuchida, Masanori
Oki, Eiji
Okuda, Shujiro
Wakai, Toshifumi
Mori, Masaki
author_sort Osoegawa, Atsushi
collection PubMed
description BACKGROUND: Tumor mutational burden (TMB) has been identified as one of the predictors for the response to anti-programmed cell death-1 (anti-PD-1) antibody therapy and reported to correlate with smoking history in lung adenocarcinoma. However, in squamous cell carcinoma of the lung, the association between TMB and clinicopathological background factors, such as smoking history, has not been reported, including in our previous study. The mutational signature is a tool to identify the mutagens that are contributing to the mutational spectrum of a tumor by investigating the pattern of DNA changes. Here, we analyzed the mutational signature in lung squamous cell carcinoma to identify mutagens affecting the TMB. METHODS: Seven representative mutational signatures including signature 7 (SI7) [ultraviolet (UV)-related], SI4 (smoking), SI6/15 [mismatch repair (MMR)], SI2/13 [apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC)], and SI5 (clock-like) were analyzed in Japanese patients with lung squamous cell carcinoma (n=67) using data generated by next-generation sequencing consisting of a 415-gene panel. The relationships between signatures and clinico-pathological data including TMB and programmed death-ligand 1 (PD-L1) expression were analyzed. RESULTS: Although the reconstructed mutational counts were small with targeted sequencing (median: 30.1, range: 13.3–98.7), the distributions of signatures were comparable among samples, with 56 cases containing more than four signatures. The smoking-related SI4 was found in 45 cases and was significantly related with pack-year index (PYI) (P=0.026). The reconstructed mutation counts were highly correlated with SI4 (r=0.51, P<0.0001), whereas the correlation was weak with SI6/15 (MMR-related) and SI2/13 (APOBEC-related). There was no mutational signature related with PD-L1 expression. Some patients exhibited unique signatures; the patient with the highest mutational counts had a MMR signature, and another patient with a prominent UV signature had occupational exposure to UV, as he was employed as a neon sign engineer. CONCLUSIONS: Mutational signatures can predict the cause of lung squamous cell carcinoma. Tobacco smoking is the mutagen most related with TMB.
format Online
Article
Text
id pubmed-7947495
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-79474952021-03-12 Mutational signatures in squamous cell carcinoma of the lung Osoegawa, Atsushi Takada, Kazuki Okamoto, Tatsuro Sato, Seijiro Nagahashi, Masayuki Tagawa, Tetsuzo Tsuchida, Masanori Oki, Eiji Okuda, Shujiro Wakai, Toshifumi Mori, Masaki J Thorac Dis Original Article BACKGROUND: Tumor mutational burden (TMB) has been identified as one of the predictors for the response to anti-programmed cell death-1 (anti-PD-1) antibody therapy and reported to correlate with smoking history in lung adenocarcinoma. However, in squamous cell carcinoma of the lung, the association between TMB and clinicopathological background factors, such as smoking history, has not been reported, including in our previous study. The mutational signature is a tool to identify the mutagens that are contributing to the mutational spectrum of a tumor by investigating the pattern of DNA changes. Here, we analyzed the mutational signature in lung squamous cell carcinoma to identify mutagens affecting the TMB. METHODS: Seven representative mutational signatures including signature 7 (SI7) [ultraviolet (UV)-related], SI4 (smoking), SI6/15 [mismatch repair (MMR)], SI2/13 [apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC)], and SI5 (clock-like) were analyzed in Japanese patients with lung squamous cell carcinoma (n=67) using data generated by next-generation sequencing consisting of a 415-gene panel. The relationships between signatures and clinico-pathological data including TMB and programmed death-ligand 1 (PD-L1) expression were analyzed. RESULTS: Although the reconstructed mutational counts were small with targeted sequencing (median: 30.1, range: 13.3–98.7), the distributions of signatures were comparable among samples, with 56 cases containing more than four signatures. The smoking-related SI4 was found in 45 cases and was significantly related with pack-year index (PYI) (P=0.026). The reconstructed mutation counts were highly correlated with SI4 (r=0.51, P<0.0001), whereas the correlation was weak with SI6/15 (MMR-related) and SI2/13 (APOBEC-related). There was no mutational signature related with PD-L1 expression. Some patients exhibited unique signatures; the patient with the highest mutational counts had a MMR signature, and another patient with a prominent UV signature had occupational exposure to UV, as he was employed as a neon sign engineer. CONCLUSIONS: Mutational signatures can predict the cause of lung squamous cell carcinoma. Tobacco smoking is the mutagen most related with TMB. AME Publishing Company 2021-02 /pmc/articles/PMC7947495/ /pubmed/33717580 http://dx.doi.org/10.21037/jtd-20-2602 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Osoegawa, Atsushi
Takada, Kazuki
Okamoto, Tatsuro
Sato, Seijiro
Nagahashi, Masayuki
Tagawa, Tetsuzo
Tsuchida, Masanori
Oki, Eiji
Okuda, Shujiro
Wakai, Toshifumi
Mori, Masaki
Mutational signatures in squamous cell carcinoma of the lung
title Mutational signatures in squamous cell carcinoma of the lung
title_full Mutational signatures in squamous cell carcinoma of the lung
title_fullStr Mutational signatures in squamous cell carcinoma of the lung
title_full_unstemmed Mutational signatures in squamous cell carcinoma of the lung
title_short Mutational signatures in squamous cell carcinoma of the lung
title_sort mutational signatures in squamous cell carcinoma of the lung
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947495/
https://www.ncbi.nlm.nih.gov/pubmed/33717580
http://dx.doi.org/10.21037/jtd-20-2602
work_keys_str_mv AT osoegawaatsushi mutationalsignaturesinsquamouscellcarcinomaofthelung
AT takadakazuki mutationalsignaturesinsquamouscellcarcinomaofthelung
AT okamototatsuro mutationalsignaturesinsquamouscellcarcinomaofthelung
AT satoseijiro mutationalsignaturesinsquamouscellcarcinomaofthelung
AT nagahashimasayuki mutationalsignaturesinsquamouscellcarcinomaofthelung
AT tagawatetsuzo mutationalsignaturesinsquamouscellcarcinomaofthelung
AT tsuchidamasanori mutationalsignaturesinsquamouscellcarcinomaofthelung
AT okieiji mutationalsignaturesinsquamouscellcarcinomaofthelung
AT okudashujiro mutationalsignaturesinsquamouscellcarcinomaofthelung
AT wakaitoshifumi mutationalsignaturesinsquamouscellcarcinomaofthelung
AT morimasaki mutationalsignaturesinsquamouscellcarcinomaofthelung